Voxel touts FDA-cleared holography
Look for 3-D holography developer Voxel to emphasize the new regulatorystatus of its technology. The Laguna Hills, CA, firm will enjoyits first RSNA meeting with Food and Drug Administration clearancefor its products (SCAN 10/11/95). Voxel uses a
Look for 3-D holography developer Voxel to emphasize the new regulatorystatus of its technology. The Laguna Hills, CA, firm will enjoyits first RSNA meeting with Food and Drug Administration clearancefor its products (SCAN 10/11/95).
Voxel uses a proprietary camera to create VoxGrams, or holographicimages, that seem to reach out into space when they are viewed.Voxel believes the enhanced perspective will help clinicians whenviewing images.
Voxel will show ongoing clinical work using VoxGrams in neurologicaland breast imaging. The company plans to begin beta-site installationsof the system next year.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.
